VOGENX INC
VOGX · NASDAQ
Updated at 2026-10-14 09:06:44
- Today's High
- $17.09
- Today’s Low
- $15.25
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $18.12
- Previous Close
- $17.14
- Volume
- 87.75K
- Market Cap
- $254.61M
- P/E Ratio
- --
- EPS
- --
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- N/A
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 3901 BARRETT DRIVE, RALEIGH, NC, UNITED STATES, 27609
- Country
- --
- Listing Date
- --
- Fiscal Year End
- December
- Shares Outstanding
- 0
- CIK
- --
- Website
- --
Vogenx, Inc. is a clinical-stage drug development company that develops therapeutics for metabolic including post-bariatric hypoglycemia, or PBH, and gastroparesis. The company is headquartered in Raleigh, North Carolina.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-06-30
$0
2025-03-31
$0
Operating Expenses
2026-06-30
$355.38K
2026-03-31
$463.15K
2025-06-30
$310.66K
2025-03-31
$372.19K
Net Income
2026-06-30
-$384.43K
2026-03-31
-$475.45K
2025-06-30
-$294.79K
2025-03-31
-$356.61K
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-06-30
--
2025-03-31
--
Earnings Per Share
2026-06-30
$-0.07
2026-03-31
--
2025-06-30
--
2025-03-31
--
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$355.38K
2026-03-31
-$463.15K
2025-06-30
-$310.66K
2025-03-31
-$372.19K
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-06-30
--
2025-03-31
--
| Item | 2026-06-30 | 2026-03-31 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $355.38K | $463.15K | $310.66K | $372.19K |
| Net Income | -$384.43K | -$475.45K | -$294.79K | -$356.61K |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-0.07 | -- | -- | -- |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$355.38K | -$463.15K | -$310.66K | -$372.19K |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.